Travoprost
Travoprost (Travoprostum) is a PGF2a analog that was launched as an ophthalmic solution administered topically for the treatment of elevated intraocular hypertension as a result of open-angle glaucoma, a common optic neuropathy, and a leading cause of blindness. It can act as an agonist of prostaglandin F receptor.
| Trivial name | Travoprostum |
| Catalog Number | S3738 |
| Molecular Formula | C26H35F3O6 |
| CAS# | 157283-68-6 |
| Inchi | InChI=1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,2 1-,22-,23+,24-/m1/s1 |
| Inchi Key | MKPLKVHSHYCHOC-AHTXBMBWSA-N |
| SMILES | CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/travoprost.html |
| Additional Information | https://file.selleck.cn/downloads/struct/travoprost-chemical-structure-s3738.gif |